Bacterial Infections
📧 Sign up to get email alerts when something new happens for Bacterial Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: Impact of Ceftriaxone and/or Fluoroquinolone (FQ) Treatment on the Gut Microbiota of Hospitalized Patients.
The clinical trial investigating how ceftriaxone and/or fluoroquinolone treatment affects gut microbiota in hospitalized patients has been t…
-
CLINICAL_TRIALS trial_result · 2015-10-30Clinical Trial Update: A Study to Test the Safety and Effectiveness of an Investigational Vaccine in Infants (V419-002) [Phase 2]
Merck's investigational vaccine V419-002 completed Phase 2 testing in infants, evaluating safety and effectiveness for bacterial and viral i…
-
CLINICAL_TRIALS trial_result · 2015-10-30Clinical Trial Update: A Study of the Safety and Tolerability of V419 in Healthy Infants at 2,4, 6 and 12 to 14 Months of Age (V419-003) [Phase 2]
Phase 2 study assessing the safety and tolerability of V419 in healthy infants at 2, 4, 6, and 12-14 months of age.
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: Safety of Fluconazole Treatment of Premature and Full-term Newborn Infants [Phase 4]
Phase 4 safety update evaluating fluconazole treatment in premature and full-term newborn infants.
-
FDA approval · 2015-08-18FDA Approved: DEMECLOCYCLINE HYDROCHLORIDE — Original Application (PuraCap Laboratories LLC)
FDA approved demeclocycline hydrochloride under an Original Application for PuraCap Laboratories LLC (ANDA065447).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: Effect of Xylitol on Oral Microbiota in Children [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluated the effect of xylitol on the oral microbiota in children; the study is completed with results pos…
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: A Single Dose Study To Investigate The Pharmacokinetics and Safety Of Dalbavancin In Hospitalized Children Aged 3 Months to 11 Years. [Phase 1]
A Phase 1 pharmacokinetics and safety study of dalbavancin in hospitalized children aged 3 months to 11 years has completed.
-
CLINICAL_TRIALS withdrawal · 2015-04-22Clinical Trial Update: A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and the Effects of GSK945237 and Moxifloxacin on QTc. [Phase 1]
This update notes the withdrawal of a Phase 1 study evaluating GSK945237 in healthy adults, including assessments of safety, pharmacokinetic…
-
CLINICAL_TRIALS trial_result · 2015-02-25Clinical Trial Update: A Multiple Dose Study of Debio 1450 [Intravenous (IV) and Oral] in Healthy Volunteers [Phase 1]
A Phase 1 multiple-dose study of Debio 1450 in healthy volunteers (administered intravenously or orally) sponsored by Debiopharm Internation…
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: To Evaluate the Effectiveness(Immunogeneicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Adults [Phase 3]
Phase 3 clinical trial update assessing the immunogenicity and safety of GC1107 administered intramuscularly in healthy adults for bacterial…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Children [Phase 2, Phase 3]
This study evaluated the immunogenicity and safety of GC1107 administered intramuscularly in healthy children in Phase 2/3; the trial has co…
-
CLINICAL_TRIALS trial_result · 2014-12-10Clinical Trial Update: WEUKBRE5555: IMI PROTECT(Work Package 2): Liver Injury & Antibiotics
Completed clinical trial WEUKBRE5555 under the IMI PROTECT program evaluating liver injury in antibiotic use for bacterial infections.
-
FDA approval · 2014-12-05FDA Approved: METRONIDAZOLE — Supplemental Application (Oceanside Pharmaceuticals)
The FDA approved a supplemental application for metronidazole submitted by Oceanside Pharmaceuticals.
-
CLINICAL_TRIALS research · 2014-11-13Clinical Trial Update: Iron Homoeostasis in Inflammation
Clinical trial on iron homeostasis in inflammatory and infectious conditions has completed, encompassing iron-deficiency anemia and iron ove…
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Validation Study of Combined Positron Emission Tomography/Computer Tomography to Diagnose Infection and Inflammation
This clinical trial update reports the termination of a validation study evaluating combined PET/CT imaging for diagnosing infection and inf…
-
CLINICAL_TRIALS trial_result · 2014-10-23Clinical Trial Update: A Single Dose Study of Debio 1450 in Healthy Subjects [Phase 1]
Phase 1 trial evaluating a single dose of Debio 1450 in healthy subjects has completed.
-
FDA approval · 2014-10-15FDA Approved: LINCOCIN — Supplemental Application (Pharmacia & Upjohn Company LLC)
The FDA approved a supplemental application for LINCOCIN (lincomycin hydrochloride) from Pharmacia & Upjohn Company LLC.
-
CLINICAL_TRIALS trial_result · 2014-07-28Clinical Trial Update: Procalcitonin for Predicting Serious Bacterial Infection in Infants Less Than 3 Months
This completed trial evaluated whether procalcitonin can predict serious bacterial infection in infants under 3 months. The study status is …
-
CLINICAL_TRIALS trial_result · 2014-04-29Clinical Trial Update: Safety, Tolerability, Pharmacokinetics of Intravenous RPX2014 and RPX7009 in Healthy Adult Subjects [Phase 1]
Phase 1 study assessing safety, tolerability, and pharmacokinetics of intravenous RPX2014 and RPX7009 in healthy adults; the trial has compl…
-
CLINICAL_TRIALS research · 2014-02-28Clinical Trial Update: Children's Antibiotic Resistant Infections in Low Income Countries
This clinical trial update notes a pediatric study on antibiotic-resistant bacterial infections in low-income countries, sponsored by Instit…
-
CLINICAL_TRIALS trial_result · 2013-09-26Clinical Trial Update: Clinical and Economic Impact of Interventions by a Clinical Pharmacist on Antibiotic Use on Surgical Wards [NA]
This completed trial evaluated how clinical pharmacist interventions affect antibiotic prescribing and related costs on surgical wards.
-
CLINICAL_TRIALS trial_result · 2013-07-24Clinical Trial Update: Safety, Tolerability, Pharmacokinetics of Intravenous RPX7009 in Healthy Adult Subjects [Phase 1]
Phase 1 trial update reporting safety, tolerability, and pharmacokinetics of intravenous RPX7009 in healthy adult subjects.
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination [Phase 1]
A Phase 1 safety study evaluating intravenous Biapenem RPX2003 and RPX7009, alone and in combination, in healthy volunteers and individuals …
-
CLINICAL_TRIALS trial_result · 2013-06-07Clinical Trial Update: Changes in Microbiota and Iron Status After Iron Fortification of Complementary Foods [NA]
This trial update reports on how iron fortification of complementary foods altered gut microbiota and iron status in participants.
-
CLINICAL_TRIALS trial_result · 2013-03-27Clinical Trial Update: Bacterial Colonization in COPD in View of CAT Under ICS+LABA Therapy
This completed trial evaluated bacterial colonization in chronic obstructive pulmonary disease patients who were treated with inhaled cortic…